Comparing two breast imaging methods before surgery
Part of Cancer, Skin clinical trials.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 30 or older
- You have been diagnosed with early-stage invasive breast cancer (T1 or T2)
- Your mammogram shows a pattern higher than BI-RADS 1
- You have never had a bad reaction to contrast dye (like iodine or gadolinium)
- Your kidney function is good (EGFR above 30) and checked within the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of mammogram (contrast-enhanced mammography, or CEM) can help doctors see additional breast findings that show up on MRI. It may help avoid unnecessary extra biopsies or surgeries.
This trial tests whether a special mammogram with contrast can help doctors see how well chemotherapy is working before breast cancer surgery. It is for women who plan to have at least 4 rounds of chemo before their operation.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This study looks at whether contrast-enhanced mammography (CEM) can find breast cancer better in women who have dense breast tissue and a personal history of breast cancer. If you've had breast cancer before and have dense breasts, this trial could help improve early detection.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.